Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey A Versporten, P Zarb, I Caniaux, MF Gros, N Drapier, M Miller, V Jarlier, ... The Lancet Global Health 6 (6), e619-e629, 2018 | 617 | 2018 |
Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries Y Hsia, BR Lee, A Versporten, Y Yang, J Bielicki, C Jackson, J Newland, ... The Lancet Global Health 7 (7), e861-e871, 2019 | 271 | 2019 |
Strategies to improve antimicrobial utilization with a special focus on developing countries B Godman, A Egwuenu, M Haque, OO Malande, N Schellack, S Kumar, ... Life 11 (6), 528, 2021 | 179 | 2021 |
Barriers for access to new medicines: searching for the balance between rising costs and limited budgets B Godman, A Bucsics, P Vella Bonanno, W Oortwijn, CC Rothe, A Ferrario, ... Frontiers in Public Health 6, 328, 2018 | 166 | 2018 |
The implementation of managed entry agreements in Central and Eastern Europe: findings and implications A Ferrario, D Arāja, T Bochenek, T Čatić, D Dankó, M Dimitrova, J Fürst, ... Pharmacoeconomics 35, 1271-1285, 2017 | 166 | 2017 |
Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries … B Godman, M Haque, J McKimm, M Abu Bakar, J Sneddon, J Wale, ... Current medical research and opinion 36 (2), 301-327, 2020 | 161 | 2020 |
Systemic measures and legislative and organizational frameworks aimed at preventing or mitigating drug shortages in 28 European and Western Asian countries T Bochenek, V Abilova, A Alkan, B Asanin, I de Miguel Beriain, Z Besovic, ... Frontiers in pharmacology 8, 942, 2018 | 118 | 2018 |
Fixed dose drug combinations–are they pharmacoeconomically sound? Findings and implications especially for lower-and middle-income countries B Godman, H McCabe, T D Leong, D Mueller, AP Martin, I Hoxha, ... Expert review of pharmacoeconomics & outcomes research 20 (1), 1-26, 2020 | 93 | 2020 |
Are pharmacists’ good knowledge and awareness on antibiotics taken for granted? The situation in Albania and future implications across countries I Hoxha, A Malaj, B Kraja, S Bino, M Oluka, V Marković-Peković, ... Journal of global antimicrobial resistance 13, 240-245, 2018 | 84 | 2018 |
The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures E Moorkens, B Godman, I Huys, I Hoxha, A Malaj, S Keuerleber, ... Frontiers in pharmacology 11, 591134, 2021 | 75 | 2021 |
Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications B Godman, A Hill, S Simoens, G Selke, I Selke Krulichová, ... Expert review of pharmacoeconomics & outcomes research 21 (4), 527-540, 2021 | 72 | 2021 |
Progress on the national action plan of Pakistan on antimicrobial resistance (AMR): A narrative review and the implications Z Saleem, B Godman, F Azhar, AC Kalungia, J Fadare, S Opanga, ... Expert review of anti-infective therapy 20 (1), 71-93, 2022 | 64 | 2022 |
Antimicrobial medicines consumption in Eastern Europeand Central Asia–an updated cross-national study and assessment of quantitativemetrics for policy action J Robertson, K Iwamoto, I Hoxha, L Ghazaryan, V Abilova, A Cvijanovic, ... Frontiers in pharmacology 9, 1156, 2019 | 62 | 2019 |
Pricing of oral generic cancer medicines in 25 European countries; findings and implications B Godman, A Hill, S Simoens, A Kurdi, J Gulbinovič, A Martin, A Timoney, ... Generics and Biosimilars Initiative Journal 8 (2), 49-70, 2019 | 54 | 2019 |
Proposal for a regulation on health technology assessment in Europe–opinions of policy makers, payers and academics from the field of HTA P Vella Bonanno, A Bucsics, S Simoens, AP Martin, W Oortwijn, ... Expert review of pharmacoeconomics & outcomes research 19 (3), 251-261, 2019 | 49 | 2019 |
Evidence-based public policy making for medicines across countries: findings and implications for the future B Godman, J Fadare, HY Kwon, CZ Dias, A Kurdi, IP Dias Godoi, ... Journal of comparative effectiveness research 10 (12), 1019-1052, 2021 | 47 | 2021 |
Antibiotic knowledge, attitudes and behaviours of Albanian health care professionals and patients–a qualitative interview study S Kaae, A Malaj, I Hoxha Journal of pharmaceutical policy and practice 10 (1), 13, 2017 | 42 | 2017 |
The current situation regarding long-acting insulin analogues including biosimilars among African, Asian, European, and South American countries; findings and implications for … B Godman, M Haque, T Leong, E Allocati, S Kumar, S Islam, J Charan, ... Frontiers in public health 9, 671961, 2021 | 39 | 2021 |
Global-PPS network A Versporten, P Zarb, I Caniaux, MF Gros, N Drapier, M Miller, V Jarlier, ... Antimicrobial consumption and resistance in adult hospital inpatients in 53 …, 0 | 30 | |
Current rates of purchasing of antibiotics without a prescription across sub-Saharan Africa; rationale and potential programmes to reduce inappropriate dispensing and resistance TM Sono, E Yeika, A Cook, A Kalungia, SA Opanga, JEE Acolatse, ... Expert review of anti-infective therapy 21 (10), 1025-1055, 2023 | 27 | 2023 |